Loss of Function
Landau–Kleffner syndrome
Genotype
Grin2a KO
Mechanism
Loss of Function
Phenotype
Seizures, Social isolation, Cognitive impairment, Auditory response, Locomotor activity, Sensorimotor activity, Anxiety, Sleep
Biomarker
S100B, NfL, BDNF, GFAP
Gene Expression Markers
GRIN1, GRIN2B, c-FOS, EGR1, CREB1, SRPX2, IL1B, TNF-α, HOMER1
Physiology Changes
EEG - Enhanced spike frequency and burst firing, Impaired long-term potentiation, Increased epileptiform activity during sleep, Disrupted theta rhythms
Histology Grading Endpoint
Neuronal loss, Disrupted layer organization, Reduced spine density, Cortical disruption and Inflammation



